About the Authors
- Munkhbold Tuul
-
Affiliations Department of Molecular Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Hiroyuki Kitao
-
* E-mail: hkitao@surg2.med.kyushu-u.ac.jp
Affiliations Department of Molecular Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Innovative anticancer strategy for therapeutics and diagnosis group, Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, Japan
- Makoto Iimori
-
Affiliation Department of Molecular Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Kazuaki Matsuoka
-
Affiliations Innovative anticancer strategy for therapeutics and diagnosis group, Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, Japan, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan
- Shinichi Kiyonari
-
Affiliation Innovative anticancer strategy for therapeutics and diagnosis group, Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, Japan
- Hiroshi Saeki
-
Affiliation Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Eiji Oki
-
Affiliation Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Masaru Morita
-
Affiliation Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Yoshihiko Maehara
-
Affiliations Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, Innovative anticancer strategy for therapeutics and diagnosis group, Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, Japan
Competing Interests
Kazuaki Matsuoka is an employee of Tokushima Research Center, Taiho Pharmaceutical Co. Ltd (Tokushima, Japan) and Hiroyuki Kitao and Makoto Iimori are staffs of university course financially maintained by donation of Taiho Pharmaceutical Co.Ltd (Department of Molecular Oncology, Kyushu University). However, these do not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
N/A. Conceived and designed the experiments: HK MM YM. Performed the experiments: MT HK KM. Analyzed the data: MT HK MI KM SK HS EO MM YM. Contributed reagents/materials/analysis tools: HK MI KM YM. Wrote the paper: MT HK MM YM.